John Howard Hutchinson,Thomas Jon Seiders,Nicholas Simon Stock
申请号：
US13387064
公开号：
US08785393B2
申请日:
2010.07.28
申请国别(地区):
US
年份:
2014
代理人:
摘要：
Described herein are ophthalmic pharmaceutical compositions, wherein the ophthalmic pharmaceutical compositions are in a form suitable for administration to an eye of a mammal. Ophthalmic pharmaceutical compositions disclosed herein include at least one DP2 receptor antagonist compound and are used to treat or prevent ophthalmic diseases or conditions.
